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 Cellular neurothekeoma preferentially affects women and 
has a predilection for the head, neck and arms of children 
and young adults. Cellular neurothekeoma is a well-
circumscribed tumor involving the reticular dermis and 
consisting of fascicles of polygonal or spindle cells with 
eosinophilic cytoplasma and neuroid characteristics. We de-
scribe an additional case of cellular neurothekeoma on the 
upper lip. Microscopically, the neoplasm had a multinodular 
or lobulated architecture that were partially or completely 
invested by a dense band of collagen and was composed of 
plump, spindled, and epithelioid cells arranged in solid, in-
filtrating nests and fascicles. Cytologically, the neoplastic 
cells were relatively large and contained lightly eosinophilic, 
finely vacuolated cytoplasm. The nuclei were round to oval 
with vesicular chromatin, with no atypical mitotic figures 
identified. Immunohistochemical examinatioa showed that 
the neoplastic cells were diffusely positive for vimentin 
and positive for NSE, but were negative for S-100 protein. 
Our case was a representative example of a typical cellular 
neurothekeoma. 
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Introduction 
 Neurothekeomas are benign neoplasms with prob-
able neural differentiation. They were described origi-
nally in 1969 by Harkin and Reed" who used the 
name nerve sheath myxoma. The term neurothekeoma 
was coined by Gallager and Helwig 2) in 1980 based on 
their 53 patients. Names including pacinian neurofibroma, 
bizarre cutaneous neurofibroma, cutaneous lobular 
neuromyxoma, and perineurial myxoma have been used 
by other authors" 4 , 5. 6) A similar lesion consisting 
predominantly of epithelioid cells with minimal mucin 
was termed cellular neurothekeoma by Rosati et al.') 
in 1986. Several years later, Barnhill and Mihm8) de-
scribed five additional cases of cellular neurothekeoma. 
In this report, we describe an additional case of cellu-
lar neurothekeoma on the upper lip.
Case report 
 The patient was a 59-year-old woman presenting 
with an asymptomatic nodule on the upper lip, which 
had been present for several years. The tumor had 
been gradually increasing in size. Clinically, the lesion 
was firm in consistency, measuring 0.7x0.7 cm in di-
ameter, and was covered by normal-appearing skin. 
The clinical diagnosis considered was histocytoma. 
The lesion was completely removed and submitted for 
microscopic examination 
 The specimens were fixed in 10% buffered formalin 
and embedded in paraffin. Sections of 4,u m thick 
were stained with hematoxylin and eosin, and alcian 
blue stain. Immunohistochemical staining was
performed using the avidin-biotin-peroxidase complex 
(ABC) method and antibodies for vimentin, neuron-
specific enolase (NSE), S-100 protein, glial fibrillary 
acidic protein (GFAP)., Leu 7 (CD57), neurofilament pro-
tein, epithelial membrane antigen (EMA), cytokeratin, 
smooth muscle actin (SM-actin), and desmin. 
 The excisional specimen revealed a rather well cir-
cumscribed tumor in the dermis. The cut surface was 
nodular, yellowish white. Microscopically, the neoplasm 
had a multinodular or lobulated architecture that were 
partially or completely invested by a dense band of 
collagen and was composed of plump, spindled, and 
epithelioid cells arranged in solid, infiltrating nests and 
fascicles (Fig 1). Cytologically, the neoplastic cells were 
relatively large and contained lightly eosinophilic,
finely vacuolated cytoplasm. The nuclei were round to 
oval with vesicular chromatin, with no atypical mi-
totic figures identified (Fig 2). The stroma consisted of 
wispy collagen fibers that tended to condense in the 
more epithelioid areas, scattered capillary-sized vessels, 
and stromal mucosubstance. Focal myxomatous change, 
demonstrated by alcian blue staining, was present. 
 Immunohistochemical examination showed that the 
neoplastic cells were diffusely positive for vimentin 
(Fig 3) and positive for NSE (Fig 4), but were negative 
for S-100 protein. The immunohistochemical results 
for this case are given in Table 1.
Figure 1. Microscopically, the neoplasm had a multinodular 
or lobulated architecture that were partially or completely in-
vested by a dense band of collagen and was composed of 
plump, spindled, and epithehoid cells arranged in solid, infil-
trating nests and fascicles. Hematoxylin & eosin, x40
igure 2. Cytologically, the neoplastic cells were relatively 
arge and contained lightly eosinophilic, finely vacuolated cy-
oplasm. The nuclei were round to oval with vesicular chro-
natin, with no atypical mitotic figures identified. Hematoxylin 
u eosin, x200
Figure 3. Immunohistochemical examination showed that the 
neoplastic cells were diffusely positive for vimentin. Vimentin, 
x200
Figure 4. Immunohistochemical examination showed that the 
neoplastic cells were positive for NSE, NSE, x200
Table 1. Results of the immunohistochemical studies 
   Vimentin + + 
   NSE + 
   S-100 -
   GFAP -
   Leu 7 -
   Neurofilament protein -
  EMA -
   Cytokeratin -
    SM-acti -
   Desmin -
  + +: diffusely positive, +: positive, -: negative
Discussion 
  Neurothekeoma occurs most commonly as a cutaneous 
neoplasm in young women. Histologically, the classic 
or myxoid type of neurothekeoma is characterized by a 
lobulated, well-circumscribed proliferation of spindle and 
epithelioid cells in varying proportions embedded in an 
abundant myxoid stroma intervened with scant colla-
gen fibers. The tumor commonly shows immunoreactivity 
to S-100 protein and vimentin, but is generally nega-
tive for other neural markers including Leu 7 (CD57), 
synaptophysin, glial fibrillary acidic protein, NSE, and 
other markers including EMA, cytokeratin, carcino-
embryonic antigen, desmin, factor VIII-related antigen, 
HMB-45, a -1-antichymotrysin, and a -1-antitrypsins' 9 10'. 
Tumor differentiation is assumed to be Schwannian 
based on ultrastructural and immunohistochemical 
studies', 11, 
 The concept of a histologic spectrum of neurothekeoma 
from myxoid to intermediate to cellular types was in-
troduced by Barnhill and Mihm$' in 1990 and by 
Husain et al." in 1994. The classic myxoid type is 
characterized by hypocellular spindle cells with abun-
dant mucin content whereas the cellular type is char-
acterized by hypercellular epithelioid cells and mini-
mal mucin content. Tumors with features of both 
cellular and myxoid types are classified as the inter-
mediate type. 
 Cellular neurothekeoma preferentially affects women 
and has a predilection for the head, neck and arms of 
children and young adults. There has been only one 
reported case of cellular neurothekeoma on the lip"). 
Cellular neurothekeoma is a well-circumscribed tumor 
involving the reticular dermis and consisting of fasci-
cles of polygonal or spindle cells with eosinophilic 
cytoplasma and neuroid characteristics. 
 A previous immunohistochemical study demonstrated
that tumor cells of cellular neurothekeoma were posi-
tive for vimentin and negative for S-100 protein"), 
while the myxoid type of neurothekeoma shows con-
sistent S-100 protein immunoreactivity10', supporting a 
Schwannian differentiation. The cell of origin of the 
cellular type of neurothekeoma is less clear due to the 
lack of S-100 protein immunoreactivity. Our findings 
support the observation that cellular neurothekeoma 
differs from the myxoid type of neurothekeoma. 
 In a study of cellular neurothekeoma, Zelger et 
al" noted additional similarities between cellular 
neurothekeoma and fibrous histiocytoma, including 
immunohistochemical expression of SM-actin. In our 
case, however, SM-actin and CD68 were not expressed. 
Although Laskin et all') reported that cellular and mixed 
neurothekeoma variants lack neurosustentacular dif-
ferentiation and may be potentially related to tumors 
included in the fibrohistiocytic category, their true ori-
gin is unclear.
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